# A MAD Study of TT301/MW189 in Healthy Volunteers

> **NCT02942771** · PHASE1 · COMPLETED · sponsor: **Linda Van Eldik** · enrollment: 35 (actual)

## Conditions studied

- Healthy Adult Volunteers

## Interventions

- **DRUG:** 0.075mg/kg TT301/MW189
- **DRUG:** 0.15mg/kg TT301MW189
- **DRUG:** 0.25mg/kg TT301/MW189
- **DRUG:** 0.30mg/kg TT301/MW189
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02942771
- **Lead sponsor:** Linda Van Eldik
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2018-06-04
- **Final completion:** 2018-06-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02942771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02942771, "A MAD Study of TT301/MW189 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02942771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*